Patent 7495014 was granted and assigned to Vertex Pharmaceuticals on February, 2009 by the United States Patent and Trademark Office.
The present invention relates to compounds which inhibit bacterial gyrase and/or Topo IV and pharmaceutically acceptable compositions comprising said compounds. These compounds, and compositions thereof, are useful in treating bacterial infection. Accordingly, the present invention also relates to methods for treating bacterial infections in mammals.